Your session is about to expire
← Back to Search
Dexmedetomidine for Anesthesia
Study Summary
This trial will use dexmedetomidine, a sedative, to study how anesthesia and artificially induced sleep affects the brain.
- Anesthesia
- Healthy Subjects
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 4 trial • 798 Patients • NCT02004613Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could I be considered a participant in this research endeavor?
"This research study is seeking out 30 adults aged 18-45 for anaesthesia therapy. To be eligible, potential participants must have no known contraindications to MRI or PET scans."
Does this experiment restrict participation to those aged 50 or younger?
"The age range for potential study enrollees is from 18 to 45 years old, as specified by the trial's eligibility requirements."
Are there still available openings for participants in this research project?
"Affirmative. Clinicaltrials.gov reveals that this medical study, which was first published on April 12th 2022, is still in search of volunteers. Approximately 30 participants need to be sourced from a single clinical centre."
How many participants are currently involved in this research endeavor?
"Affirmative. The clinical trial data on clinicaltrials.gov reveals that this research study is actively seeking participants and began recruitment on April 12th, 2022 with a recent update issued June 23rd of the same year. A total of 30 patients are needed from 1 medical site for enrollment in the trial."
Share this study with friends
Copy Link
Messenger